Oncologic Thermoradiotherapy

<p>The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy. This is partially due to the lack of level I evidence from international multicentric randomized clinical trials including large patient numbers and a long term follow-up. Therefore we need more level I EVIDENCE from clinical trials we need <em>HARMONISATION</em> and global acceptance for existing technologies and a common language understood by all stakeholders and we need INNOVATION in the fields of biology clinics and technology to move thermotherapy/hyperthermia forward. This is the main focus of this reprint. </p><p><br></p><p>In this reprintyou find carefully selected and peer-reviewed contributions from Africa America Asia and Europe. The published papers from leading scientists from all over the world covering a broad range of timely research topics might also help to strengthen thermotherapy on a global level.</p>